MetLife Investment Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $836K | Sell |
19,238
-3,367
| -15% | -$146K | ﹤0.01% | 1403 |
|
|
2025
Q1 | $845K | Sell |
22,605
-355
| -2% | -$13.3K | ﹤0.01% | 1446 |
|
|
2024
Q4 | $1.04M | Buy |
22,960
+1,845
| +9% | +$83.6K | 0.01% | 1387 |
|
|
2024
Q3 | $1.24M | Buy |
21,115
+80
| +0.4% | +$4.7K | 0.01% | 1266 |
|
|
2024
Q2 | $828K | Sell |
21,035
-194
| -0.9% | -$7.63K | ﹤0.01% | 1444 |
|
|
2024
Q1 | $1.41M | Buy |
21,229
+10,591
| +100% | +$704K | 0.01% | 1115 |
|
|
2023
Q4 | $297K | Hold |
10,638
| – | – | ﹤0.01% | 2009 |
|
|
2023
Q3 | $227K | Buy |
+10,638
| New | +$227K | ﹤0.01% | 2134 |
|